Atherosclerosis
Volume 199, Issue 2 , Pages 390-396 , August 2008

Improved resistance to serum oxidation in Gilbert's syndrome: A mechanism for cardiovascular protection

  • Andrew C. Bulmer

      Affiliations

    • School of Human Movement Studies, University of Queensland, St. Lucia, Queensland 4067, Australia
    • School of Molecular and Microbial Sciences, University of Queensland, St. Lucia, Queensland 4067, Australia
    • Biopharma Pty. Ltd., 2/67 Richland Avenue, Coopers Plains, Queensland 4108, Australia
    • Corresponding Author InformationCorresponding author at: School of Human Movement Studies, Blair Drive, University of Queensland, St. Lucia, Queensland 4067, Australia. Tel.: +61 7 3365 6767; fax: +61 7 3365 6877.
    • ,
  • Joanne T. Blanchfield

      Affiliations

    • School of Molecular and Microbial Sciences, University of Queensland, St. Lucia, Queensland 4067, Australia
    • ,
  • Istvan Toth

      Affiliations

    • School of Molecular and Microbial Sciences, University of Queensland, St. Lucia, Queensland 4067, Australia
    • School of Pharmacy, University of Queensland, St. Lucia, Queensland 4067, Australia
    • ,
  • Robert G. Fassett

      Affiliations

    • Launceston General Hospital, Launceston, Tasmania 7250, Australia
    • ,
  • Jeff S. Coombes

      Affiliations

    • School of Human Movement Studies, University of Queensland, St. Lucia, Queensland 4067, Australia

Received 27 September 2007 ,Revised 1 November 2007 ,Accepted 15 November 2007.

References 

  1. Fertrin KY, Goncalves MS, Saad ST, Costa FF. Frequencies of UDP-glucuronosyltransferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil. Am J Med Genet. 2002;108:117–119
  2. van Es HH, Bout A, Liu J, et al. Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. Cytogenet Cell Genet. 1993;63:114–116
  3. Ihara H, Hashizume N, Shimizu N, Aoki T. Threshold concentration of unbound bilirubin to induce neurological deficits in a patient with type I Crigler-Najjar syndrome. Ann Clin Biochem. 1999;36(Pt 3):347–352
  4. Vitek L, Jirsa M, Brodanova M, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis. 2002;160:449–456
  5. Lin JP, O’Donnell CJ, Schwaiger JP, et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation. 2006;114:1476–1481
  6. Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood). 2003;228:568–571
  7. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043–1046
  8. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem. 1994;269:16712–16719
  9. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA. 1988;85:9748–9752
  10. Kontush A, Spranger T, Reich A, et al. Whole plasma oxidation assay as a measure of lipoprotein oxidizability. Biofactors. 1997;6:99–109
  11. Wiedemann M, Kontush A, Finckh B, Hellwege HH, Kohlschutter A. Neonatal blood plasma is less susceptible to oxidation than adult plasma owing to its higher content of bilirubin and lower content of oxidizable fatty acids. Pediatr Res. 2003;53:843–849
  12. Kaplan M, Levy-Lahad E, Hammerman C, Renbaum P, Halevy J. Sex distribution in Gilbert's syndrome. Isr Med Assoc J. 2001;3:989
  13. Brower JO, Lightner DA, McDonagh AF. Aromatic congeners of bilirubin: synthesis, stereochemistry, glucuronidation and hepatic transport. Tetrahedron. 2001;57:7813–7827
  14. Schnitzer E, Pinchuk I, Bor A, et al. Lipid oxidation in unfractionated serum and plasma. Chem Phys Lipids. 1998;92:151–170
  15. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond). 1993;84:407–412
  16. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239:70–76
  17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  18. Sim AS, Salonikas C, Naidoo D, Wilcken DE. Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. J Chromatogr B Anal Technol Biomed Life Sci. 2003;785:337–344
  19. Madesh M, Balasubramanian KA. Microtiter plate assay for superoxide dismutase using MTT reduction by superoxide. Indian J Biochem Biophys. 1998;35:184–188
  20. Slaughter MR, O’Brien PJ. Fully-automated spectrophotometric method for measurement of antioxidant activity of catalase. Clin Biochem. 2000;33:525–534
  21. Wheeler CR, Salzman JA, Elsayed NM, Omaye ST, Korte DW. Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem. 1990;184:193–199
  22. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA. 2002;99:16093–16098
  23. Surekha RH, Srikanth BB, Jharna P, et al. Oxidative stress and total antioxidant status in myocardial infarction. Singapore Med J. 2007;48:137–142
  24. Karten B, Beisiegel U, Gercken G, Kontush A. Mechanisms of lipid peroxidation in human blood plasma: a kinetic approach. Chem Phys Lipids. 1997;88:83–96
  25. Polidori MC, Mecocci P, Levine M, Frei B. Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasma to ex vivo lipid peroxidation. Arch Biochem Biophys. 2004;423:109–115
  26. Spranger T, Finckh B, Fingerhut R, et al. How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper. Chem Phys Lipids. 1998;91:39–52
  27. Hopkins PN, Wu LL, Hunt SC, et al. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1996;16:250–255
  28. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381–1478
  29. Burkitt MJ. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin. Arch Biochem Biophys. 2001;394:117–135
  30. Dabbagh AJ, Frei B. Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems. J Clin Invest. 1995;96:1958–1966
  31. Nakayama M, Takahashi K, Komaru T, et al. Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2001;21:1373–1377
  32. Stadler N, Lindner RA, Davies MJ. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol. 2004;24:949–954
  33. Schwertner HA, Fischer JR. Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease. Atherosclerosis. 2000;150:381–387
  34. Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal. 2004;6:841–849
  35. Vitek L, Kraslova I, Muchova L, Novotny L, Yamaguchi T. Urinary excretion of oxidative metabolites of bilirubin in subjects with Gilbert syndrome. J Gastroenterol Hepatol. 2007;22:841–845
  36. Kalousova M, Novotny L, Zima T, Braun M, Vitek L. Decreased levels of advanced glycation end-products in patients with Gilbert syndrome. Cell Mol Biol (Noisy-le-grand). 2005;51:387–392
  37. Inoguchi T, Sasaki S, Kobayashi K, Takayanagi R, Yamada T. Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA. 2007;298:1398–1400
  38. Vitek L, Malikova I, Kvasnicka J, Benakova H, Novotny L. Relationship between serum bilirubin and markers of inflammation and oxidative stress. J Gastroenterol Hepatol. 2007;22:A235

PII: S0021-9150(07)00744-7

doi: 10.1016/j.atherosclerosis.2007.11.022

Atherosclerosis
Volume 199, Issue 2 , Pages 390-396 , August 2008

Article Tools

* Image Usage & Resolution